Prognosis value of baseline total metabolic tumor volume (TMTV) in advanced Hodgkin lymphoma (HL) : Ancillary study of AHL2011 LYSA trial - Université de Bourgogne Accéder directement au contenu
Communication Dans Un Congrès Année : 2016

Prognosis value of baseline total metabolic tumor volume (TMTV) in advanced Hodgkin lymphoma (HL) : Ancillary study of AHL2011 LYSA trial

Fichier non déposé

Dates et versions

hal-01472426 , version 1 (20-02-2017)

Identifiants

  • HAL Id : hal-01472426 , version 1

Citer

Salim Kanoun, Alina Berriolo-Riedinger, Ilan Tal,, V Edeline,, Anne Ségolène Cottereau, et al.. Prognosis value of baseline total metabolic tumor volume (TMTV) in advanced Hodgkin lymphoma (HL) : Ancillary study of AHL2011 LYSA trial. Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), European-Association-of-Nuclear-Medicine (EANM), Oct 2016, Barcelone, Spain. pp.S125-S126 ; Meeting Abstract: OP406. ⟨hal-01472426⟩
476 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More